Roxbury Financial’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.2K Buy
507
+2
+0.4% +$181 0.03% 217
2026
Q2
$46.3K Buy
505
+2
+0.4% +$175 0.04% 207
2026
Q1
$42.9K Sell
503
-52
-9% -$4.64K 0.04% 202
2025
Q4
$43.9K Buy
555
+2
+0.4% +$157 0.04% 195
2025
Q3
$44.2K Buy
553
+101
+22% +$8.62K 0.04% 189
2025
Q2
$41K Buy
452
+2
+0.4% +$183 0.04% 192
2025
Q1
$41K Buy
450
+2
+0.4% +$179 0.04% 182
2024
Q4
$43.4K Buy
+448
New +$42.8K 0.04% 174

Other funds holding CL

Roxbury Financial's CL Position: Q3 2026 in Review

Roxbury Financial increased its Colgate-Palmolive (CL) stake by 0.4% in Q3 2026, buying an estimated $181 and bringing the position to 507 shares worth $43.2K. The position accounts for 0.03% of the portfolio, ranked #217.

Roxbury Financial first reported a position in CL in Q4 2024 and has held it in 8 quarters since. The position peaked at $46.3K in Q2 2026. 1,131 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Roxbury Financial held 507 shares of Colgate-Palmolive worth $43.2K as of Q3 2026.
  • Roxbury Financial bought 2 Colgate-Palmolive shares in Q3 2026, an estimated $181.
  • Colgate-Palmolive made up 0.03% of Roxbury Financial's portfolio in Q3 2026, its #217 holding.
  • Roxbury Financial first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 8 quarters since.
  • Roxbury Financial's Colgate-Palmolive position peaked at $46.3K in Q2 2026.
  • 1,131 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.